Naveen Pemmaraju: Honored to speak and moderate two key sessions at the 16th International MPN Congress
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas , shared a post on LinkedIn:
“Honored to speak and moderate 2 key sessions at the 16th International MPN Congress in Brooklyn NYC this week!! My invited talk was on “Novel Agents in MPNs for 2024.”
Special thanks to Dr Richard Silver & Dr Jerry Spivak for the kind invitation to come back to present here. Thanks to Mrs Heather Newton & team for the awesome support and organization.
An amazing meeting & wonderful educational forum for our MPN community.”
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023